Viral Collection and Transport

Media, swabs and kit supply you can count on

At Thermo Fisher Scientific Microbiology, we have remained focused and flexible to ramp up production and deliver the products that you rely on. This is all to meet your testing demands during the coronavirus pandemic and beyond.

Our brand new, state-of-the-art facilities in both the US and UK have allowed us to upscale to 8 million viral collection and transport kits per week.

Our mission remains to enable our customers to make the world healthier, cleaner and safer.

Select your product mix by asking our experts:

Contact us


Broad flexible product range

Innovation in Culture Media

8 million tubes manufactured per week

Quality you can rely on


Our viral collection and transport media portfolio


Thermo Scientific™ InhibiSURE™ Viral Inactivation Medium*:

Collect and rapidly inactivate the SARS-CoV-2 virus, stabilizing viral RNA at ambient temperature for transport and use in in vitro diagnostic testing procedures using a non-hazardous formula.

Learn more ›


Thermo Scientific™ MicroTest™ Viral Collection and Transport Media:

Maintain organism viability and counts for verification studies, quality control procedures, and repeat testing of viruses, chlamydiae, mycoplasma and ureaplasma.

Learn more ›

Longhorn PrimeStore® Molecular Transport Medium (MTM):

Stabilize, transport and inactivate infectious, unprocessed nasal washes suspected of containing Influenza A virus RNA, as well as infectious unprocessed sputum samples suspected of containing Mycobacterium tuberculosis DNA from human samples.

Learn more ›

Spectrum™ SDNA: 

Simplify the collection of saliva for commercial bioinformatic DNA testing applications, academic, research, biobanking, and as a bio-sample collection option for DNA and viral RNA for COVID-19 testing.

Learn more ›


Validating a quick, safer, more productive SARS-CoV-2 testing pathway with The Francis Crick Institute

Protect your staff

Help keep your staff safe with our new InhibiSURE Viral Inactivation Medium*—a non-hazardous inactivation medium now for the collection and transport of all RNA enveloped viruses, including SARS-CoV-2, RSV, influenza A and Parainfluenza 3.

Learn more about what “non-hazardous” actually means, and how the InhibiSURE formulation works with Part 2 of our SmartNote series, InhibiSURE: What is a non-hazardous collection and transport medium?

Read SmartNote

Nasal-self-collection-device-brichure-cover-450x250

InhibiSURE Medium is also available as part of our new Thermo Scientific™ Self Collection Kit, a CE-IVD marked self-collection kit for nasal samples.*

View brochure

* This product is suitable for use by: Adults aged 18 and over. Ages 14 - 17 under supervision by an individual over 18. Samples for children under the age of 13 years should be collected by an individual over 18.



Keeping microbiology supply chains open during coronavirus

Keeping microbiology supply chains open during coronavirus

When healthcare systems are working at full capacity, they need the unwavering support of their supply chains. High demand for SARS-CoV-2 testing has seen many companies redeploy capacity and resources.

Our latest research looks at the consequences of supply shortages on routine healthcare, antimicrobial resistance, and the system’s ability to mount an effective pandemic response – as well as what we at Thermo Fisher Scientific are doing to maintain both supply of traditional testing and viral sample collection materials.

Download the SmartNote


Longhorn Vaccines and Diagnostics LLC is the legal manufacturer of PrimeStore MTM. PrimeStore® is a trademark of Longhorn Vaccines and Diagnostics LLC. PrimeStore MTM is distributed globally by Thermo Fisher Scientific.

Spectrum Solutions is the legal manufacturer of Spectrum SDNA. Spectrum SDNA is a trademark of Spectrum Solutions. Spectrum SDNA is distributed globally by Thermo Fisher Scientific.

Not all products are available for sale in all territories.
*Product is CE marked but not 510(k)-cleared and not available for sale in the U.S. Availability of product in each country depends on local regulatory marketing authorization status.